Literature DB >> 25631475

Hallucinogen Persisting Perception Disorder and Risk of Suicide.

Joy Brodrick1, Brian G Mitchell2.   

Abstract

A 30-year-old male patient developed a hallucinogen persisting perception disorder (HPPD) after smoking cannabis laced with phencyclidine (PCP) or lysergic acid diethylamide (LSD) 10 years prior to hospital admission. Clinically, he reported seeing vivid, saturated colors and caricature-like objects. The patient described perceiving objects or people in motion as moving faster than normal. He reported living in a dream-like state and feeling numb and detached from other people and his surroundings. Upon pharmacotherapy initiation, facility transfer, and subsequent discharge from an acute psychiatry unit, he ultimately committed suicide. Although hallucinogen abuse is common in the United States, this case suggests that HPPD maybe significantly underdiagnosed and undertreated. In some cases, this oversight may perpetuate years of unnecessary patient suffering and can ultimately lead to severe depression and suicide.
© The Author(s) 2015.

Entities:  

Keywords:  death; hallucinogen; hallucinogen persistent perception disorder; mortality; suicide

Mesh:

Substances:

Year:  2015        PMID: 25631475     DOI: 10.1177/0897190014566314

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  6 in total

1.  Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.

Authors:  Kevin H Yang; Benjamin H Han; Joseph J Palamar
Journal:  Addict Behav       Date:  2022-04-28       Impact factor: 4.591

2.  Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature.

Authors:  Hannah Ford; Clare L Fraser; Emma Solly; Meaghan Clough; Joanne Fielding; Owen White; Anneke Van Der Walt
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

Review 3.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

Review 4.  The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

Authors:  Laura Orsolini; Gabriele Duccio Papanti; Domenico De Berardis; Amira Guirguis; John Martin Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2017-11-20       Impact factor: 4.157

Review 5.  Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

Authors:  Giovanni Martinotti; Rita Santacroce; Mauro Pettorruso; Chiara Montemitro; Maria Chiara Spano; Marco Lorusso; Massimo di Giannantonio; Arturo G Lerner
Journal:  Brain Sci       Date:  2018-03-16

6.  Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report.

Authors:  David Haslacher; Nikolina Novkovic; Maria Buthut; Andreas Heinz; Surjo R Soekadar
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.